Seeking Alpha

Delcath (DCTH) shares -9.7% after it says its chemosaturation system was not effective in...

Delcath (DCTH) shares -9.7% after it says its chemosaturation system was not effective in patients with colorectal cancer in a mid-stage trial. The blow comes a week after the same treatment was shown to be effective in treating primary liver cancer. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|